# FDA Inspection 819182 - CSL Plasma Inc. - February 20, 2013

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/692291ae-2437-4ff2-b5c1-5bcfa87d8d9c
Source feed: FDA_Inspections

> FDA Inspection 819182 for CSL Plasma Inc. on February 20, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 819182
- Company Name: CSL Plasma Inc.
- Inspection Date: 2013-02-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1194612 - 2022-12-16](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/d5df9c87-b3e6-415e-a17d-a58ba0962a12)
- [FDA Inspection 1074767 - 2018-11-21](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/d2a77160-30c5-4f24-b780-f76339ca4b88)
- [FDA Inspection 944254 - 2015-09-11](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/929a611f-a6f7-4a27-8452-0979418698af)
- [FDA Inspection 697816 - 2010-11-15](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/9d305d82-f4ac-46b6-a36e-0af407485429)
- [FDA Inspection 555841 - 2009-01-13](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/a1408343-d27f-4c75-a461-7d3d1e4bb17e)

Company: https://www.keypedia.com/companies/csl-plasma-inc/a89d79f9-86ca-4331-8ef9-2fb08e4bcc1c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d